Followers | 54 |
Posts | 10318 |
Boards Moderated | 0 |
Alias Born | 12/01/2005 |

Tuesday, August 19, 2014 2:54:18 PM
Recent UGA News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/27/2025 02:38:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2025 07:39:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2025 01:20:35 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/25/2025 08:16:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2025 04:50:28 PM
- Form 424I - • Edgar (US Regulatory) • 03/28/2025 09:27:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2025 02:07:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2025 03:42:59 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/28/2025 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2025 03:06:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2025 01:39:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2024 02:57:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2024 05:15:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2024 05:54:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/29/2024 07:49:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/30/2024 01:36:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2024 01:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:33:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/29/2024 12:55:19 PM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM